Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3 Promising Growth Companies With Insider Ownership Up To 38%

In This Article:

As global markets experience broad-based gains with U.S. indexes nearing record highs, investors are navigating a landscape marked by strong labor market data and stabilizing economic indicators. In such an environment, growth companies with significant insider ownership can be particularly appealing, as they often signal confidence from those who know the business best and align management interests with shareholders.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Seojin SystemLtd (KOSDAQ:A178320)

31.1%

43.2%

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.3%

SKS Technologies Group (ASX:SKS)

32.4%

24.8%

Laopu Gold (SEHK:6181)

36.4%

34.2%

Medley (TSE:4480)

34%

31.7%

Findi (ASX:FND)

34.8%

71.5%

Elliptic Laboratories (OB:ELABS)

26.8%

103.6%

Fulin Precision (SZSE:300432)

13.6%

66.7%

Brightstar Resources (ASX:BTR)

16.2%

84.6%

Click here to see the full list of 1514 stocks from our Fast Growing Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Alibaba Health Information Technology

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Alibaba Health Information Technology Limited operates in pharmaceutical direct sales, pharmaceutical e-commerce platforms, and healthcare and digital services in Mainland China and Hong Kong, with a market cap of HK$57.41 billion.

Operations: The company generates revenue from the distribution and development of pharmaceutical and healthcare business, amounting to CN¥28.34 billion.

Insider Ownership: 19.3%

Alibaba Health Information Technology shows strong growth potential with earnings increasing by 47.7% over the past year and a forecasted annual growth of 21.5%, outpacing the Hong Kong market's average. Recent earnings reported for the half-year ended September 2024 showed sales of CNY 14.27 billion, up from CNY 12.96 billion a year earlier, and net income rising significantly to CNY 768.95 million, reflecting robust operational performance despite share price volatility and low forecasted return on equity (13%).

SEHK:241 Earnings and Revenue Growth as at Nov 2024
SEHK:241 Earnings and Revenue Growth as at Nov 2024

XGD

Simply Wall St Growth Rating: ★★★★☆☆

Overview: XGD Inc., along with its subsidiaries, is involved in the research, development, manufacturing, sales, and servicing of payment terminals both in China and internationally, with a market cap of CN¥13.73 billion.